<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02187614</url>
  </required_header>
  <id_info>
    <org_study_id>IRB Number: 14-00059</org_study_id>
    <secondary_id>Hamad Medical Corporation-MRC</secondary_id>
    <nct_id>NCT02187614</nct_id>
  </id_info>
  <brief_title>Efficacy Study of Different Analgesic Options in Kidney Stone Pain Management</brief_title>
  <official_title>A Double Blind, Multi-arm Randomized Control Trial, for Efficacy of Intramuscular Diclofenac Versus Intravenous Morphine Versus Intravenous Paracetamol, in Renal Colic Emergency Department Pain Management</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hamad Medical Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hamad Medical Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Abdominal pain is one of the most common presentations to an emergency department (ED). Among&#xD;
      patients presenting with abdominal pain, a common diagnosis in the Middle East is renal colic&#xD;
      (urolithiasis or Kidney stones). As the patients with renal colic writhe around in agonizing&#xD;
      pain, the first priority in an ED from a patient's perspective is fast and safe analgesia and&#xD;
      to be pain free as early as possible. There are variations in physician preference to choose&#xD;
      initial analgesic drug for managing such pain. Commonly used drugs are:&#xD;
&#xD;
        -  Opioids such as Morphine or Fentanyl&#xD;
&#xD;
        -  Non steroidal drugs such as Diclofenac, Ketorolac or Brufen&#xD;
&#xD;
        -  and Paracetamol intravenous injection.&#xD;
&#xD;
      A robust evidence in comparison of diclofenac versus morphine and paracetamol is lacking.&#xD;
      This study is design to obtain data on efficacy of these three drugs within 30 minutes in a&#xD;
      non inferiority trail.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This will be a double blind RCT, where participants will be enrolled consecutively after&#xD;
      meeting eligibility criteria and obtaining a written informed consent. They will be assign to&#xD;
      one of the three study arms by computer generated randomization process. The study packets&#xD;
      will be prepared by a dedicated nurse or pharmacist who will not a part of investigating&#xD;
      team. Each Patients will receive one analgesic drug (active drug) and two placebos. Drugs&#xD;
      will be given as one intramuscular injection and two intravenous solutions.&#xD;
&#xD;
      Pain score will be recorded using NRS at 0, 30, 60, and 90 minutes. Data will be collected on&#xD;
      standard Data collection form. Each participant will receive analgesia from study packet&#xD;
      which contains, one active drug and two placebos to be administer as one intramuscular and&#xD;
      two intravenous solutions. At any given time every patient will receive one analgesia from&#xD;
      either Diclofenac, Paracetamol or Morphine. If patient pain does not respond to initial&#xD;
      treatments, at 30 minutes a rescue analgesia in form of morphine will be administered till&#xD;
      patient is pain free or NRS&lt;=2 or adverse event to morphine.&#xD;
&#xD;
      Based on the results of previous studies (1-3), proportion of patients achieving more than&#xD;
      50% pain reduction, is between 65-75% for diclofenac, morphine and paracetamol when compared&#xD;
      with other drugs. In each group, 437 patients are required to detect a difference of 10% in&#xD;
      primary outcome, in a superiority trial with power (1-beta) of 90% and significance level&#xD;
      (alpha) of 5% in this study. Considering 15% extra, total sample size required in this&#xD;
      superiority trial will be 1507 patients in total.&#xD;
&#xD;
      Data will be collected on a standard data recording form and it will be converted to&#xD;
      electronic excel sheet hiding patient identifiable details. Continuous variables will be&#xD;
      presented as mean with standard deviation (SD). Categorical variables will be calculated as&#xD;
      proportions and presented with 95% Confidence interval (CI). Statistical analyses will be&#xD;
      undertaken using Stata 12.0 (College Station, Texas).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2014</start_date>
  <completion_date type="Actual">March 2015</completion_date>
  <primary_completion_date type="Actual">February 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The proportion of patients achieving a reduction of &gt;50% on Numerical Rating Scale (NRS-11) from the initial NRS recorded at the end of 30 minutes in each study arm.</measure>
    <time_frame>at 30 minutes after analgesia</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>reduction in mean NRS</measure>
    <time_frame>at 30, 60 and 90 minutes after analgesia</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>adverse event rate</measure>
    <time_frame>Within 14 days of ED visit</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>total analgesia requirement to get pain score (NRS) less than or equal to 2.</measure>
    <time_frame>by 90 minutes</time_frame>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">1645</enrollment>
  <condition>Renal Colic</condition>
  <condition>Urinary Calculi</condition>
  <arm_group>
    <arm_group_label>Diclofenac and Placebos</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this group will receive a Diclofenac 75 mg intramuscular injection, and two placebo saline solutions intravenously.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Morphine and Placebos</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants in this group will receive Morphine 0.1 mg/kg intravenously, along with an additional intravenous placebo and an intramuscular placebo injection.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Paracetamol and Placebos</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>participants in this group will receive intravenous Paracetamol 1 gm solution, along with an additional intravenous placebo and an intramuscular placebo injection.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Diclofenac</intervention_name>
    <arm_group_label>Diclofenac and Placebos</arm_group_label>
    <other_name>Voltaren</other_name>
    <other_name>Diclofen</other_name>
    <other_name>Diclorex</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine</intervention_name>
    <arm_group_label>Morphine and Placebos</arm_group_label>
    <other_name>Morphine sulphate</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Paracetamol</intervention_name>
    <arm_group_label>Paracetamol and Placebos</arm_group_label>
    <other_name>Perfalgan</other_name>
    <other_name>Acetaminophen</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebos</intervention_name>
    <arm_group_label>Diclofenac and Placebos</arm_group_label>
    <arm_group_label>Morphine and Placebos</arm_group_label>
    <arm_group_label>Paracetamol and Placebos</arm_group_label>
    <other_name>saline solution</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age &gt;=18 years and &lt; 65 years&#xD;
&#xD;
          -  Acute onset, one side flank or loin pain, with or without radiation to groin or&#xD;
             genital areas.&#xD;
&#xD;
          -  Pain intensity on NRS more than or equal to 4. (Moderate to Severe Pain)&#xD;
&#xD;
          -  Diagnosis confirmed by non contrast CT KUB within the ED visit.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Traumatic flank pain&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Known renal failure or impairment&#xD;
&#xD;
          -  Known allergy to morphine, diclofenac or paracetamol&#xD;
&#xD;
          -  Bronchial asthma&#xD;
&#xD;
          -  Previously enrolled in the study.&#xD;
&#xD;
          -  Use of any analgesia in last 6 hour.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dr.Sameer A. Pathan, MBBS, MCEM</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hamad Medical Corporation</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Prof. Peter A Cameron, MD,FACEM</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hamad Medical Corporation</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Emergency Department, Hamad General Hospital.</name>
      <address>
        <city>Doha</city>
        <zip>3050</zip>
        <country>Qatar</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Qatar</country>
  </location_countries>
  <reference>
    <citation>Grissa MH, Claessens YE, Bouida W, Boubaker H, Boudhib L, Kerkeni W, Boukef R, Nouira S. Paracetamol vs piroxicam to relieve pain in renal colic. Results of a randomized controlled trial. Am J Emerg Med. 2011 Feb;29(2):203-6. doi: 10.1016/j.ajem.2009.09.019. Epub 2010 Oct 8.</citation>
    <PMID>20934829</PMID>
  </reference>
  <reference>
    <citation>Behzadnia MJ, Javadzadeh HR, Saboori F. Time of admission, gender and age: challenging factors in emergency renal colic - a preliminary study. Trauma Mon. 2012 Fall;17(3):329-32. doi: 10.5812/traumamon.6800. Epub 2012 Oct 10.</citation>
    <PMID>24350118</PMID>
  </reference>
  <reference>
    <citation>Shaden Salameh; Nurit Hiller; Meir Antopolsky; Fedaa Ghanem; Yigaal Abramovitz; Ruth Stalnikowics. Diclofenac versus Tramadol in the Treatment of Renal Colic: A Prospective, Randomized Trial. The Open Emergency Medicine Journal. 2011; 4: 9-13.</citation>
  </reference>
  <verification_date>March 2015</verification_date>
  <study_first_submitted>July 7, 2014</study_first_submitted>
  <study_first_submitted_qc>July 10, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 11, 2014</study_first_posted>
  <last_update_submitted>March 17, 2015</last_update_submitted>
  <last_update_submitted_qc>March 17, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 18, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hamad Medical Corporation</investigator_affiliation>
    <investigator_full_name>Dr. SAMEER PATHAN</investigator_full_name>
    <investigator_title>Research Fellow and Specialist</investigator_title>
  </responsible_party>
  <keyword>Acute Renal colic</keyword>
  <keyword>Acute Ureteric Colic</keyword>
  <keyword>Renal or Ureteral Calculi</keyword>
  <keyword>Urolithiasis</keyword>
  <keyword>Kidney or Ureteral stones</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Calculi</mesh_term>
    <mesh_term>Urolithiasis</mesh_term>
    <mesh_term>Colic</mesh_term>
    <mesh_term>Calculi</mesh_term>
    <mesh_term>Renal Colic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Diclofenac</mesh_term>
    <mesh_term>Morphine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

